Hemophagocytosis and relapsed peripheral T-cell lymphoma.
- Published in:
- 2009
- By:
- Publication type:
- Other
Works matching IS 09024441 AND DT 2009 AND VI 82 AND IP 3
Results: 15
1
2
A case of severe aplastic anemia secondary to treatment with lenalidomide for multiple myeloma.
- Published in:
- European Journal of Haematology, 2009, v. 82, n. 3, p. 231, doi. 10.1111/j.1600-0609.2008.01176.x
- By:
- Publication type:
- Article
3
Possible application of flow cytometry for evaluation of the structure and functional status of WASP in peripheral blood mononuclear cells.
- Published in:
- European Journal of Haematology, 2009, v. 82, n. 3, p. 223, doi. 10.1111/j.1600-0609.2008.01180.x
- By:
- Publication type:
- Article
4
Clinical significance of regulatory T cells in patients with myelodysplastic syndrome.
- Published in:
- European Journal of Haematology, 2009, v. 82, n. 3, p. 201, doi. 10.1111/j.1600-0609.2008.01182.x
- By:
- Publication type:
- Article
5
Efficacy and safety of fotemustine for the treatment of relapsed and refractory multiple myeloma patients.
- Published in:
- 2009
- By:
- Publication type:
- Letter
6
Pseudotumour cerebri as a manageable side effect of prolonged all-trans retinoic acid therapy in an adult patient with acute promyelocytic leukaemia.
- Published in:
- 2009
- By:
- Publication type:
- Letter
7
Catastrophic tumour lysis syndrome following single dose of imatinib.
- Published in:
- 2009
- By:
- Publication type:
- Letter
8
Rituximab to treat chronic lymphoproliferative disorder-associated pure red cell aplasia.
- Published in:
- European Journal of Haematology, 2009, v. 82, n. 3, p. 235, doi. 10.1111/j.1600-0609.2008.01187.x
- By:
- Publication type:
- Article
9
Small molecule inhibitors of WNT signaling effectively induce apoptosis in acute myeloid leukemia cells.
- Published in:
- European Journal of Haematology, 2009, v. 82, n. 3, p. 165, doi. 10.1111/j.1600-0609.2008.01188.x
- By:
- Publication type:
- Article
10
Combination of DNA methylation inhibitor 5-azacytidine and arsenic trioxide has synergistic activity in myeloma.
- Published in:
- European Journal of Haematology, 2009, v. 82, n. 3, p. 176, doi. 10.1111/j.1600-0609.2008.01189.x
- By:
- Publication type:
- Article
11
Long-term follow-up of interferon-alpha induction and low-dose maintenance therapy in hairy cell leukemia.
- Published in:
- European Journal of Haematology, 2009, v. 82, n. 3, p. 194, doi. 10.1111/j.1600-0609.2008.01190.x
- By:
- Publication type:
- Article
12
Hypocholesterolemia in adult patients with thalassemia: a link with the severity of genotype in thalassemia intermedia patients.
- Published in:
- European Journal of Haematology, 2009, v. 82, n. 3, p. 219, doi. 10.1111/j.1600-0609.2008.01195.x
- By:
- Publication type:
- Article
13
Echocardiographic finding in beta-thalassemia intermedia and major: absence of pulmonary hypertension following hydroxyurea treatment in beta-thalassemia intermedia.
- Published in:
- European Journal of Haematology, 2009, v. 82, n. 3, p. 213, doi. 10.1111/j.1600-0609.2008.01192.x
- By:
- Publication type:
- Article
14
Efficacy and safety of pegylated liposomal doxorubicin in primary cutaneous B-cell lymphomas and comparison with the commonly used therapies.
- Published in:
- European Journal of Haematology, 2009, v. 82, n. 3, p. 184, doi. 10.1111/j.1600-0609.2008.01197.x
- By:
- Publication type:
- Article
15
Contact factor deficiencies and cardiopulmonary bypass surgery: detection of the defect and monitoring of heparin.
- Published in:
- European Journal of Haematology, 2009, v. 82, n. 3, p. 208, doi. 10.1111/j.1600-0609.2008.01191.x
- By:
- Publication type:
- Article